Activated B-cell lymphoma pathogenesis exhibits irregular initiation of the BTK–mediated B-cell receptor signaling pathway [26] based on the genetic mutation in the BCR signaling pathways (Figure 1A). The gene discussed is BTK; the disease is B-cell non-Hodgkin lymphoma.